Health Disparities And The Rollout Of Long-Acting Injectable Art And Prep

Health disparities and the rollout of long-acting injectable ART and PrEP

UCSF Center for AIDS Prevention Studies (CAPS) & Prevention Research Center (PRC)

Long-Acting Injectable PrEP and HIV Treatment Microlearning

Long-Acting Injectable PrEP and HIV Treatment Podcast

Operationalizing Use of Long-Acting Injectable ART

MWAETC: Project ECHO

HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City (20444)

Ryan White HIV/AIDS Program TargetHIV

Long-Acting Injectable Cabotegravir: the Future of HIV PrEP?

MWAETC: Project ECHO

PrEP and PEP: HIV Prevention

Preparing for Pharmacy-based Delivery of Long-Acting Injectable HIV Antiretrovirals

UCSF Center for AIDS Prevention Studies (CAPS) & Prevention Research Center (PRC)

When Can Clinicians Expect Long-Acting Injectable ART?

Making PrEP accessible: Updates on long-acting injectable options

IAS – the International AIDS Society

NHS approve breakthrough HIV injection treatment rollout

Evening Standard

Expectations For Upcoming Long-Acting ART

Acceptability of long-acting injectable antiretroviral therapy among AYLHIV in Sou... - Elona Toska

Academic Medical Education

The Challenges That Come With Long-Acting Injectables

Making a SPLASH! Long-acting Injectables for vulnerable populations with HIV

Clinical Education Initiative

Discussion: Current Oral Regimens versus Long-Acting Injectables - Chen Seong Wong & Laura Waters

Academic Medical Education

Long-acting Injectable HIV Treatment Implementation and Coordination (20674)

Ryan White HIV/AIDS Program TargetHIV

Long-Acting Injectable PrEP is Here: Implementation and Capacity Building Opportunities

Long Acting Pre Exposure Prophylaxis (PrEP)

Ikechukwu Nwosu